Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether in high-risk kidney transplant patients
(patients whose previous kidney transplant failed, have a high PRA lab test result or are of
African-American descent) that a combination of Rapamune with Prograf and steroids will
prevent acute rejection as well as Rapamune and cyclosporine and steroids.